Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

2
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
2
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

2
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
2

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing PI4KIIIα Levels or Activity Limits Tau Seed Internalization and Assembly in Human Cortical Neurons.

Cells·2026
Same author

Evaluating the phosphorus-induced tolerance mechanism in <i>Brassica juncea</i> exposed to arsenic.

Physiology and molecular biology of plants : an international journal of functional plant biology·2026
Same author

Label-free 3D virtual histology of human formalin-fixed paraffin-embedded (FFPE) prostate needle biopsies with propagation-based phase-contrast micro-CT (PBCT).

bioRxiv : the preprint server for biology·2026
Same author

Adult ileocolic intussusception with lymphoma as the lead point: a case report.

Journal of surgical case reports·2026
Same author

Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis.

Frontiers in oncology·2026
Same author

Composite Meshes: A Comprehensive Review of Materials, Biomechanics, Clinical Outcomes, and Emerging Innovations.

Cureus·2026

Related Experiment Video

Updated: Jun 11, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K

Management options for node-positive muscle-invasive bladder cancer.

Hyma V Polimera1, Priyanka Bhatia1, Megan Wheelden1

  • 1Department of Medicine, Division of Hematology-Oncology, Penn State Cancer Institute, Hershey, Pennsylvania.

Clinical Advances in Hematology & Oncology : H&O
|October 2, 2024
PubMed
Summary

Node-positive bladder cancer shows varied survival due to heterogeneity and lack of standard treatments. This review explores pathophysiology, management, and new therapies for urothelial cell carcinoma to improve patient outcomes.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.4K
Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.6K

Related Experiment Videos

Last Updated: Jun 11, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.4K
Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.6K

Area of Science:

  • Oncology
  • Urology

Background:

  • Localized node-positive bladder cancer presents significant heterogeneity.
  • Variability in survival outcomes necessitates better management strategies.
  • Lack of standardized treatment guidelines poses a challenge.

Purpose of the Study:

  • To review the pathophysiology, clinical significance, and management of node-positive bladder cancer.
  • To critically evaluate the current therapeutic landscape.
  • To explore emerging treatment strategies and novel drugs in clinical trials.

Main Methods:

  • Comprehensive literature review.
  • Synthesis of latest research findings.
  • Critical evaluation of existing and novel therapeutic approaches.

Main Results:

  • Node-positive bladder cancer is heterogeneous with diverse survival.
  • Current management lacks standardized guidelines.
  • Emerging therapies show promise for urothelial cell carcinoma.

Conclusions:

  • Optimal management of node-positive bladder cancer requires a comprehensive approach.
  • Further research into novel treatments is crucial.
  • Improved patient outcomes and quality of life are the ultimate goals.